Exam 1 Lecture 5 Flashcards
What kind of drug is Mitomycin C? (MOA)
Dose limiting
Functions as alkylating agent, although toxicity pattern differs slightly from other alkylating agents.
Myelosuppression is dose limiting
MOA of platinum drugs? What is the original prototype?
They are covalent crosslinkers. Cisplatin is the original prototype.
What does cisplatin turn into inside of the cell?
Cisplatin turns into aquo form inside of cell.
Aquo form is highly reactive and a potent electrophile
What do aquo forms react rapidly with?
Aquo forms react rapidly with other nucleophiles, especially thiols
What type of cross links do platinum drugs form? What is the use of this?
Cross links are often intrastrand. Intra strand cis plat cross links impose severe geometrical constraints on DNA
What base pairs do aquo forms primarily act on?
Guanine N-7 and adenine N-7 in DNA
What are the geometric constraints on DNA platinum drugs impose
Introduce sharp bend in cross linked strand.
lesion not readily repaired by standard DNA repair enzymes
What is the major difference between platinum and alkylators?
The type of cross link it forms and side effect profile
Side effects of cis platin (dose limiting)
Dose limiting- nephrotoxicity
severe N/V
minimal bone marrow toxicity
peripheral neuropathy
drug resistance mechanism of cisplatin (2 main ones)
- Increased expression of glutathione-s-transferase (GST)
- increased intracellular concentration of non-protein thiols, especially glutathione
Why would increased expression of GST cause resistance to cisplatin
Free thiols have extremely high reactivity toward electrophilic intermediates
Thiols intercept the reactive intermediates of alkylating agents
Free thiol levels > 10-fold higher in alkylating agent-resistant cells
GST catalyzes the reaction of glutathione with alkylating agents (parent
drugs as well as reactive intermediates)
Why would increased concentration of non protein thiols cause resistance to cisplatin
Free thiols have extremely high reactivity towards electrophilic intermediates
Thiols intercept the reactive intermediates of alkylating agents
̈ Free thiol levels > 10-fold higher in alkylating agent-resistant cells
o block hemorrhagic cystitis, Mesna is coadministered with
which drug?
A. Methotrexate
B. Cyclophosphamide
C. Cisplatin
D. Mitomycin C
cyclophosphamide
Which of the following is NOT a crosslinker?
A. Cytarabine
B. Cyclophosphamide
C. Carboplatin
D. Chlorambucil
cytarabine
what do topoisomerases do?
topoisomerases provide a mechanism to reduce localized supercoiling and provide access to double stranded DNA by enzymes responsible for replication, transcription and repair.
What are the different kinds of topoisomerase inhibitors and Name their drugs (along with what stage they inhibit)
Topo I inhibitor- Irinotecan (targets S phase (DNA replication))
Topo II inhibitor- etoposide and bleomycin (Target G2 phase (sister chromatid separation))
Topo 2 intercalator- doxorubicin- non cell cycle specific
Topoisomerase I MOA
Topo I inhibitor MOA
Type I topoisomerase cuts one strand of double stranded DNA, relaxes remaining strand and reanneal.
Topo I inhibition provides a physical barrier to replication and transcription (acts as a road block)
Clinically relevant topoisomerase inhibitors bind to and form
a ternary drug-enzyme-DNA complex Inhibitor binding stabilizes Topo-DNA complex and blocks DNA re-
ligation
Cells in what phase are most sensitive to Topo I cleavage
Cells in S phase
Drug resistance of Topo I inhibitor
P-glycoprotein (PGP) overexpression
̈ Multidrug resistant protein (MRP) overexpression
̈ Glutathione S-transferase overexpression